Evaluation of Breast Specimens after Neoadjuvant Chemotherapy
Friday, February 19, 2021 Lurie Cancer Center & Hematology/Oncology Grand Rounds Evaluation of Breast Specimens after Neoadjuvant Chemotherapy: Current Concepts and Future Directions Kalliopi Siziopikou, MD, PhD, Northwestern University Feinberg School of Medicine

▶︎
Locally Advanced Breast Cancer

▶︎
50- Triple Negative Breast Cancer

▶︎
USCAP: Laura Collins' Breast Pathology

▶︎
Sampling and Evaluating Lung Nodules and Masses: Expert Q&A

▶︎
Choosing Health Insurance That’s Right for Cancer Patients

▶︎
Melanocytic Dermpath Basics: Melanoma

▶︎
Residual cancer burden after neoadjuvant therapy and long-term survival outcomes in breast cancer

▶︎
Breast Pathology Community of Interest meeting 13 December 2021.mp4

▶︎
Breast Cancer: Ductal Carcinoma in Situ (DCIS) EXPLAINED

▶︎
Balancing Work and Cancer

▶︎
Education Webinar: Skin Sarcoidosis

▶︎
#PATHBOARDS High Yield Breast Pathology for Boards

▶︎
Inflammatory Dermpath 101 (A Beginner's Guide to Diagnosing Skin Rashes for Non-Dermatopathologists)

▶︎
Breast Cancer Q&A Webinar on Triple Negative Breast Cancer

▶︎
CASE PRESENTATION - Locally Advanced Breast Cancer

▶︎
Quantitative Data Sciences Core Clinical Informatics: Clinical Data for Cancer Research

▶︎
Small Fiber Neuropathy and ARA-290 Results

▶︎
PsychCase360: Choosing the Right Long-Acting Injectable for Patients With Schizophrenia

▶︎
Breast Cancer Pathology Results - Podcast - Episode 3 - with Dr Tasha

▶︎
